Management of aggressive B-cell NHLs in the AYA population: an adult vs pediatric perspective

被引:36
作者
Dunleavy, Kieron [1 ]
Gross, Thomas G. [2 ]
机构
[1] George Washington Univ, Ctr Canc, Washington, DC 20037 USA
[2] NCI, Ctr Global Hlth, Bethesda, MD 20892 USA
关键词
NON-HODGKIN-LYMPHOMA; DOSE-ADJUSTED EPOCH; GERMINAL CENTER; RITUXIMAB-CHOP; CHEMOTHERAPY; CHILDREN; GENE; EXPRESSION; MUTATIONS; ADOLESCENTS;
D O I
10.1182/blood-2018-02-778480
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The adolescents and young adult (AYA) population represent a group wherein mature B-cell lymphomas constitute a significant proportion of the overall malignancies that occur. Among these are aggressive B-cell non-Hodgkin lymphomas (NHLs), which are predominantly diffuse large B-cell lymphoma, primary mediastinal B-cell lymphoma, and Burkitt lymphoma. For the most part, there is remarkable divide in how pediatric/adolescent patients (under the age of 18 years) with lymphoma are treated vs their young adult counterparts, and molecular data are lacking, especially in pediatric and AYA series. The outcome for AYA patients with cancers has historically been inferior to that of children or older adults, highlighting the necessity to focus on this population. This review discusses the pediatric vs adult perspective in terms of how these diseases are understood and approached and emphasizes the importance of collaborative efforts in both developing consensus for treatment of this population and planning future research endeavors.
引用
收藏
页码:369 / 375
页数:7
相关论文
共 61 条
[1]   Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling [J].
Alizadeh, AA ;
Eisen, MB ;
Davis, RE ;
Ma, C ;
Lossos, IS ;
Rosenwald, A ;
Boldrick, JG ;
Sabet, H ;
Tran, T ;
Yu, X ;
Powell, JI ;
Yang, LM ;
Marti, GE ;
Moore, T ;
Hudson, J ;
Lu, LS ;
Lewis, DB ;
Tibshirani, R ;
Sherlock, G ;
Chan, WC ;
Greiner, TC ;
Weisenburger, DD ;
Armitage, JO ;
Warnke, R ;
Levy, R ;
Wilson, W ;
Grever, MR ;
Byrd, JC ;
Botstein, D ;
Brown, PO ;
Staudt, LM .
NATURE, 2000, 403 (6769) :503-511
[2]   Cancer in 15-to 29-year-olds by primary site [J].
Bleyer, Archie ;
Viny, Aaron ;
Barr, Ronald .
ONCOLOGIST, 2006, 11 (06) :590-601
[3]   Adult high-grade B-cell lymphoma with Burkitt lymphoma signature: genomic features and potential therapeutic targets [J].
Bouska, Alyssa ;
Bi, Chengfeng ;
Lone, Waseem ;
Zhang, Weiwei ;
Kedwaii, Ambreen ;
Heavican, Tayla ;
Lachel, Cynthia M. ;
Yu, Jiayu ;
Ferro, Roberto ;
Eldorghamy, Nanees ;
Greiner, Timothy C. ;
Vose, Julie ;
Weisenburger, Dennis D. ;
Gascoyne, Randy D. ;
Rosenwald, Andreas ;
Ott, German ;
Campo, Elias ;
Rimsza, Lisa M. ;
Jaffe, Elaine S. ;
Braziel, Rita M. ;
Siebert, Reiner ;
Miles, Rodney R. ;
Dave, Sandeep ;
Reddy, Anupama ;
Delabie, Jan ;
Staudt, Louis M. ;
Song, Joo Y. ;
McKeithan, Timothy W. ;
Fu, Kai ;
Green, Michael ;
Chan, Wing C. ;
Iqbal, Javeed .
BLOOD, 2017, 130 (16) :1819-1831
[4]  
Burke GAA, 2017, BLOOD S1, V130
[5]   Double hit lymphoma: from biology to therapeutic implications [J].
Burotto, Mauricio ;
Berkovits, Alejandro ;
Dunleavy, Kieron .
EXPERT REVIEW OF HEMATOLOGY, 2016, 9 (07) :669-678
[6]   Results of a randomized international study of high-risk central nervous system B non-Hodgkin lymphoma and B acute lymphoblastic leukemia in children and adolescents [J].
Cairo, Mitchell S. ;
Gerrard, Mary ;
Sposto, Richard ;
Auperin, Anne ;
Pinkerton, C. Ross ;
Michon, Jean ;
Weston, Claire ;
Perkins, Sherrie L. ;
Raphael, Martine ;
McCarthy, Keith ;
Patte, Catherine .
BLOOD, 2007, 109 (07) :2736-2743
[7]   The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications [J].
Campo, Elias ;
Swerdlow, Steven H. ;
Harris, Nancy L. ;
Pileri, Stefano ;
Stein, Harald ;
Jaffe, Elaine S. .
BLOOD, 2011, 117 (19) :5019-5032
[8]   Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte [J].
Coiffier, Bertrand ;
Thieblemont, Catherine ;
Van Den Neste, Eric ;
Lepeu, Gerard ;
Plantier, Isabelle ;
Castaigne, Sylvie ;
Lefort, Sophie ;
Marit, Gerald ;
Macro, Margaret ;
Sebban, Catherine ;
Belhadj, Karim ;
Bordessoule, Dominique ;
Ferme, Christophe ;
Tilly, Herve .
BLOOD, 2010, 116 (12) :2040-2045
[9]   Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: a phase 3 comparison of dose intensification with 14-day versus 21-day cycles [J].
Cunningham, David ;
Hawkes, Eliza A. ;
Jack, Andrew ;
Qian, Wendi ;
Smith, Paul ;
Mouncey, Paul ;
Pocock, Christopher ;
Ardeshna, Kirit M. ;
Radford, John A. ;
McMillan, Andrew ;
Davies, John ;
Turner, Deborah ;
Kruger, Anton ;
Johnson, Peter ;
Gambell, Joanna ;
Linch, David .
LANCET, 2013, 381 (9880) :1817-1826
[10]   HUMAN C-MYC ONC GENE IS LOCATED ON THE REGION OF CHROMOSOME-8 THAT IS TRANSLOCATED IN BURKITT-LYMPHOMA CELLS [J].
DALLAFAVERA, R ;
BREGNI, M ;
ERIKSON, J ;
PATTERSON, D ;
GALLO, RC ;
CROCE, CM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1982, 79 (24) :7824-7827